Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes

NCT00743808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11510

Last updated 2015-12-02

No results posted yet for this study

Summary

Twelve health organizations from around the US were selected to participate in a chart review Hypertension and Diabetes Initiative with the goal of improving blood pressure control in persons with diabetes.

Hypothesis:

A three-phase quality improvement initiative facilitated and monitored through the International Diabetes Center (IDC) will result in improved population-mean systolic blood pressure in the aggregate data pool of patients from all 12 participating sites at geographically distinct health systems.

Conditions

Interventions

OTHER

quality improvement

3-phase quality improvement intervention

Sponsors & Collaborators

  • Advocate Medical Group

    collaborator OTHER
  • Baystate Health

    collaborator OTHER
  • William Beaumont Hospitals

    collaborator OTHER
  • Columbia Park Medical Group

    collaborator OTHER
  • Humboldt Del Norte Independent Practice Association

    collaborator UNKNOWN
  • Metropolitan Health

    collaborator UNKNOWN
  • Park Nicollet Clinic

    collaborator OTHER
  • PeaceHealth Medical Group

    collaborator OTHER
  • Sanford Clinic

    collaborator UNKNOWN
  • TriHealth Inc.

    collaborator OTHER
  • University Hospitals Medical Practices

    collaborator UNKNOWN
  • Warren Clinic

    collaborator UNKNOWN
  • Novartis

    collaborator INDUSTRY
  • HealthPartners Institute

    lead OTHER

Principal Investigators

  • Margaret A Powers, PhD · International Diabetes Center - Park Nicollet Institute

  • Robert M Cuddihy, MD · International Diabetes Center - Park Nicollet Institute

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2008-05-31
Completion
2010-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00743808 on ClinicalTrials.gov